Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 6, 2024; 12(16): 2758-2764
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2758
Table 1 Comparison of general data between the two groups
General information
Combined therapy group (n = 86)
Control group (n = 82)
t/χ2 value
P value
Age (yr)29.43 ± 3.5429.19 ± 3.810.4230.673
Reproductive history, n (%)0.1510.697
    Primipara57 (66.28)52 (63.41)
    Multipara29 (33.72)30 (36.59)
Gestational age at delivery (wk)38.98 ± 1.3538.76 ± 1.281.0830.280
First stage labor duration (min)505.54 ± 163.08508.67 ± 161.230.1250.901
Second-stage labor duration (min)83.75 ± 23.1484.59 ± 22.760.2370.813
Third-stage labor duration (min)9.18 ± 3.239.34 ± 3.080.3280.743
Neonatal weight (kg)3.25 ± 0.873.29 ± 0.920.1380.772
Table 2 Comparison of clinical indicators between the two groups
Clinical indicators
Combined therapy group (n = 86)
Control group (n = 82)
t/χ2 value
P value
Time of first spontaneous urination after delivery (h)2.92 ± 1.043.61 ± 1.134.121< 0.001
First postpartum urine volume (mL)163.54 ± 24.67143.72 ± 23.955.280< 0.001
Bladder residual urine volume (mL)54.81 ± 10.7865.25 ± 13.525.547< 0.001
Postpartum hemorrhage volume (mL)323.15 ± 46.95348.12 ± 45.033.5150.001
Waiting time for urination (min)0.94 ± 0.311.29 ± 0.426.165< 0.001
PUR occurrence4 (4.65)13 (15.85)5.7920.016
Table 3 Comparison of clinical efficacy between the two groups, n (%)
Group
Number
Remarkable result
In force
Null and void
Total efficacy rates
Combined therapy group8659 (68.60)23 (26.75)4 (4.65)82 (95.35)
Control group8234 (41.46)35 (42.69)13 (15.85)69 (84.15)
χ2 value5.792
P value0.016